BindingDB logo
myBDB logout

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26301559 10 Exploration of the molecular architecture of the orthosteric binding site in thea4ß2 nicotinic acetylcholine receptor with analogs of 3-(dimethylamino)butyl dimethylcarbamate (DMABC) and 1-(pyridin-3-yl)-1,4-diazepane.EBI University Of Copenhagen
23256554 16 Synthesis, pharmacology, and biostructural characterization of novela4ß2 nicotinic acetylcholine receptor agonists.EBI University Of Copenhagen
22243960 88 Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.EBI Vu University Amsterdam
20828128 66 Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptora7 ligands.EBI Vu University Amsterdam
22928944 12 Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands toa4ß2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.EBI University Of Illinois At Chicago
21986237 18 Docking studies of benzylidene anabaseine interactions witha7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of relateda7 selective ligands.EBI Targacept
21920761 52 Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.EBI Vu University Amsterdam
19331415 23 Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.EBI Institute
18754612 12 Molecular engineering of conotoxins: the importance of loop size to alpha-conotoxin structure and function.EBI University Of Queensland
27775713 21 Small-molecule factor D inhibitors targeting the alternative complement pathway.BDB Novartis Pharma
27282729 22 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A1 receptor.BDB Universit?? Di Napoli Federico Ii
27552286 22 FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.BDB Avanti Polar Lipids